Intraocular bevacizumab for macular edema due to CRVO. A multifocal-ERG and OCT study

Documenta Ophthalmologica

Volumn 116, Issue 2, 2008, Pages 147-152

  Moschos, Marilita M ^a   Moschos, Michael ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Bevacizumab (Avastin); Central retinal vein occlusion (CRVO); Macular edema; Multifocal electroretinogram (MFERG); Optical coherence tomography (OCT)

Indexed keywords

BEVACIZUMAB; TRIAMCINOLONE ACETATE; VASCULOTROPIN ANTIBODY;

ADULT; AGED; ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; DRUG EFFICACY; DRUG USE; ELECTRIC POTENTIAL; ELECTRORETINOGRAPHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; MALE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; RETINA FOVEA; RETINA MACULA EDEMA; TREATMENT DURATION; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; ELECTRORETINOGRAPHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; MACULAR EDEMA; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 39649091623     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10633-007-9110-9     Document Type: Article

References (13)

1. The Central Vein Occlusion Study Group (1997) Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 115:486-491
2. The Central Vein Occlusion Study Group (1995) Evaluation of grid laser pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology 102:1425-1433
3. Noma H, Minamoto A, Funatsu H et al (2006) Intravitreal levels of endothelial growth factor and interleukin-6 are connected with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 244:309-315
4. Spandau UH, Ihlorf AK, Jost BJ (2006) Intravitreal bevacizumab treatment of macular oedema due to central retinal vein occlusion. Acta Ophthalmol Scand 84:555-556
5. Iturralde D, Spaide RF, Meyerle CB et al (2006) Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 26:279-284
6. Costa RA, Jorge R, Calluci D, Melo L, Cardilllo J, Scott IU (2007) Intravitreal bevacizumab (Avastin) for central and hemicentral retinal vein occlusions: IBeVO study. Retina 27:141-149
7. Spandau U, Wickenhauser A, Rench F, Jonas J (2007) Intravitreal bevacizumab for branch retinal vein occlusion. Acta Ophthalmol Scand 85:118
8. Sutter E, Tran D (1992) The field topography of ERG components in man-I. The photopic luminance response. Vision Res 32:433-446
9. Hood D (2000) Assessing retinal function with the multifocal technique. Prog Retin Eye Res 19:607-646
10. Marmor MF, Hood DC, Keating D, Kondo M, Seeliger MW, Miyake Y (2003) International Society for Clinical Electrophysiology of Vision. Guidelines for basic multifocal electroretinography (mfERG). Doc Ophthalmol 106(3):338
11. Rosenfeld PG, Fung AE, Pulliafito CA (2005a) Optical coherence tomography findings after intravitreal injection of bevacizumab (Avastin) from macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 36:336-339
12. Rosenfeld PG, Moshfeghi AA, Puliafito CA (2005b) Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 36:331-335
13. Ip M, Kahama A, Altaweel M (2003) Treatment of central retinal vein occlusion with triamcinolone acetonide: An optical coherence tomography study. Semin Ophthalmol 18:67-73